Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q81294084)
Watch
English
Rifapentine
scientific article published on 01 March 2008
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18486059
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18486059%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020
review article
1 reference
stated in
Europe PubMed Central
title
Rifapentine
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18486059
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18486059%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020
publication date
1 March 2008
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18486059
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18486059%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020
published in
Tuberculosis
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18486059
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18486059%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020
volume
88
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18486059
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18486059%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020
issue
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18486059
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18486059%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020
page(s)
155-158
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18486059
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18486059%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020
cites work
Relationship between antimycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1472-9792%2808%2970025-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Rapid detection of rifampin resistance in Mycobacterium tuberculosis isolates by heteroduplex analysis and determination of rifamycin cross-resistance in rifampin-resistant isolates
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1472-9792%2808%2970025-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antimicrobial activity of rifabutin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1472-9792%2808%2970025-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of the in vitro activities of rifapentine and rifampicin against Mycobacterium tuberculosis complex
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1472-9792%2808%2970025-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Activity of rifapentine and its metabolite 25-O-desacetylrifapentine compared with rifampicin and rifabutin against Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis and M. bovis BCG.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1472-9792%2808%2970025-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
In vivo activities of newer rifamycin analogs against Mycobacterium avium infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1472-9792%2808%2970025-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
In vitro postantibiotic effects of rifapentine, isoniazid, and moxifloxacin against Mycobacterium tuberculosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1472-9792%2808%2970025-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Rifapentine is active in vitro and in vivo against Toxoplasma gondii
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1472-9792%2808%2970025-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antituberculosis activity of once-weekly rifapentine-containing regimens in mice. Long-term effectiveness with 6- and 8-month treatment regimens
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1472-9792%2808%2970025-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1472-9792%2808%2970025-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Preventive therapy of tuberculosis with rifapentine in immunocompetent and nude mice
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1472-9792%2808%2970025-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effectiveness of once-weekly rifapentine and moxifloxacin regimens against Mycobacterium tuberculosis in mice
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1472-9792%2808%2970025-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficient intermittent rifapentine-moxifloxacin-containing short-course regimen for treatment of tuberculosis in mice.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1472-9792%2808%2970025-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacokinetics of rifapentine at 600, 900, and 1,200 mg during once-weekly tuberculosis therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1472-9792%2808%2970025-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Low isoniazid concentrations and outcome of tuberculosis treatment with once-weekly isoniazid and rifapentine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1472-9792%2808%2970025-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1472-9792%2808%2970025-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The early bactericidal activities of rifampin and rifapentine in pulmonary tuberculosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1472-9792%2808%2970025-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1472-9792%2808%2970025-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Weekly moxifloxacin and rifapentine is more active than the denver regimen in murine tuberculosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1472-9792%2808%2970025-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacokinetics of rifapentine, a new long lasting rifamycin, in the rat, the mouse and the rabbit
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1472-9792%2808%2970025-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S1472-9792(08)70025-8
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18486059
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18486059%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020
PubMed publication ID
18486059
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18486059
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18486059%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit